We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$379B
AUM Growth
+$17B
(+4.7%)
Cap. Flow
-$9.66B
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
3,324
New
55
Increased
1,013
Reduced
1,512
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$970M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$569M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$462M |
| 4 |
Oracle
ORCL
|
+$420M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$385M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.46B |
| 2 |
Costco
COST
|
+$914M |
| 3 |
Meta Platforms (Facebook)
META
|
+$891M |
| 4 |
Apple
AAPL
|
+$796M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.65% |
| 2 | Financials | 12.53% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Communication Services | 9.44% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Viridian Therapeutics
VRDN
$2.13B
| $3.49M | ﹤0.01% |
161,868
-61,367
| -27% | -$1.11M |
|
2052
The RMR Group
RMR
$338M
| $3.49M | ﹤0.01% |
222,012
+99,780
| +82% | +$1.67M |
|
|
UNIT
2053
Uniti Group
UNIT
$2.46B
| $3.49M | ﹤0.01% |
570,514
-400,759
| -41% | -$2.4M |
|
2054
Artivion
AORT
$1.33B
| $3.49M | ﹤0.01% |
82,438
-2,424
| -3% | -$91.4K |
|
|
INN
2055
Summit Hotel Properties
INN
$766M
| $3.49M | ﹤0.01% |
635,018
-30,853
| -5% | -$168K |
|
|
DX
2056
Dynex Capital
DX
$3.2B
| $3.48M | ﹤0.01% |
283,091
+105,638
| +60% | +$1.32M |
|
2057
Ceco Environmental
CECO
$3.59B
| $3.47M | ﹤0.01% |
67,773
+3,470
| +5% | +$147K |
|
2058
Dentsply Sirona
XRAY
$2.77B
| $3.45M | ﹤0.01% |
271,783
-32,687
| -11% | -$474K |
|
2059
Enovix
ENVX
$825M
| $3.44M | ﹤0.01% |
345,197
-62,220
| -15% | -$689K |
|
|
STKL
2060
DELISTED
SunOpta
STKL
| $3.44M | ﹤0.01% |
587,210
+230,420
| +65% | +$1.43M |
|
2061
Papa John's
PZZA
$993M
| $3.43M | ﹤0.01% |
71,169
-2,265
| -3% | -$105K |
|
2062
Century Aluminum
CENX
$4.17B
| $3.42M | ﹤0.01% |
116,653
-2,153
| -2% | -$48.8K |
|
2063
Greif
GEF
$4.87B
| $3.42M | ﹤0.01% |
57,293
| – | – |
|
2064
IPG Photonics
IPGP
$3.45B
| $3.42M | ﹤0.01% |
43,141
-4,585
| -10% | -$358K |
|
2065
Turning Point Brands
TPB
$1.51B
| $3.4M | ﹤0.01% |
34,441
-687
| -2% | -$62.2K |
|
|
SCS
2066
DELISTED
Steelcase
SCS
| $3.4M | ﹤0.01% |
197,787
| – | – |
|
2067
ManpowerGroup
MAN
$2.61B
| $3.4M | ﹤0.01% |
89,714
-7,030
| -7% | -$290K |
|
2068
Aurinia Pharmaceuticals
AUPH
$1.92B
| $3.37M | ﹤0.01% |
305,233
+39,272
| +15% | +$429K |
|
|
PSTL
2069
Postal Realty Trust
PSTL
$702M
| $3.35M | ﹤0.01% |
213,687
-13,836
| -6% | -$209K |
|
2070
Sylvamo
SLVM
$1.54B
| $3.35M | ﹤0.01% |
75,760
-1,370
| -2% | -$63.5K |
|
2071
Vericel Corp
VCEL
$2.36B
| $3.33M | ﹤0.01% |
105,694
| – | – |
|
2072
Apogee Therapeutics
APGE
$10.1B
| $3.31M | ﹤0.01% |
83,291
| – | – |
|
2073
Sarepta Therapeutics
SRPT
$1.62B
| $3.31M | ﹤0.01% |
171,640
-2,644
| -2% | -$47.1K |
|
2074
Mineralys Therapeutics
MLYS
$2.35B
| $3.3M | ﹤0.01% |
86,916
+9,269
| +12% | +$200K |
|
2075
Toyota
TM
$229B
| $3.29M | ﹤0.01% |
17,202
-3,959
| -19% | -$746K |
|
Similar funds
VFT
Nuveen's Q3 2025 Portfolio in Review
As of Q3 2025, Nuveen held 3,324 positions worth $379B, up 4.7% from $362B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 3.8%. Nuveen opened 55 new positions and exited 70, leaving the 3,324-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q3 2025 buy was Arm: 911,376 shares worth $129M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2025, an estimated $970M increase.
- Nuveen's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.46B.
- Nuveen fully exited Hess in Q3 2025, selling an estimated $162M.
- Nuveen's ten largest holdings make up 35% of its $379B portfolio in Q3 2025.
- Nuveen opened 55 new positions and closed 70 in Q3 2025.
- Nuveen's portfolio value rose 4.7% quarter-over-quarter to $379B.
Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.